<DOC>
	<DOCNO>NCT00744016</DOCNO>
	<brief_summary>The purpose study compare maintenance mild moderate ulcerative colitis remission six month treatment 1.5 gram mesalamine pellet day versus placebo .</brief_summary>
	<brief_title>Mesalamine Pellet Formulation Maintain Remission Mild Moderate Ulcerative Colitis</brief_title>
	<detailed_description>This phase 3 , multicenter , double-blind , randomize , placebo control study evaluate effectiveness safety eMG 1.5 g give daily ( QD ) compare placebo approximately 300 subject demonstrate remission UC . Eligible subject randomize 2:1 ratio ( active : placebo ) receive 1 2 treatment : 1.5g eMG QD ( four capsule total ) match placebo capsule QD 6 month . The study consist Screening phase ( complete within 7 day prior randomization ) , Treatment phase ( 6 month ) , Follow-up visit ( 2 week end-of-study [ EOS ] visit ) . The Treatment phase consist 4 schedule study visit : Visit 1 ( Baseline ) /Randomization ( Day 1 ) , Visit 2 ( Month 1 ) , Visit 3 ( Month 3 ) , Visit 4/EOS ( Month 6 ) . Primary objective : To compare maintenance remission mild moderate ulcerative colitis ( UC ) measure rectal bleeding endoscopic mucosal appearance 6 month treatment encapsulate mesalamine granule ( eMG ) 1.5 g QD , compare placebo . Secondary objective : To compare safety tolerability long-term dosing eMG 1.5 g QD compare placebo maintenance remission mild moderate UC .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Confirmed diagnosis ulcerative colitis remission least 1 month . Greater 18 year age . Allergy/intolerance aspirin , mesalamine salicylate . Prior bowel surgery appendectomy . Pregnancy , risk pregnancy lactate . HIV hepatitis B C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>UC</keyword>
	<keyword>Ulcerative colitis</keyword>
	<keyword>IBD</keyword>
	<keyword>Inflammatory bowel disease</keyword>
</DOC>